Correlation of KIT and PDGFRA mutational status with clinical benefit in patients with gastrointestinal stromal tumor treated with sunitinib in a worldwide treatment-use trial

Peter Reichardt, George D. Demetri, Hans Gelderblom, Piotr Rutkowski, Seock-Ah Im, Sudeep Gupta, Yoon-Koo Kang, Patrick Schöffski, Jochen Schuette, Denis Soulières, Jean-Yves Blay, David Goldstein, Kolette Fly, Xin Huang, Massimo Corsaro, Maria Jose Lechuga, Jean-Francois Martini, Michael C. Heinrich

Open source

DOI: 10.1186/s12885-016-2051-5
Published: 2016-01-15
Container: BMC Cancer
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s12885-016-2051-5,
  title = {Correlation of KIT and PDGFRA mutational status with clinical benefit in patients with gastrointestinal stromal tumor treated with sunitinib in a worldwide treatment-use trial},
  author = {Peter Reichardt and George D. Demetri and Hans Gelderblom and Piotr Rutkowski and Seock-Ah Im and Sudeep Gupta and Yoon-Koo Kang and Patrick Schöffski and Jochen Schuette and Denis Soulières and Jean-Yves Blay and David Goldstein and Kolette Fly and Xin Huang and Massimo Corsaro and Maria Jose Lechuga and Jean-Francois Martini and Michael C. Heinrich},
  year = {2016},
  journal = {BMC Cancer},
  doi = {10.1186/s12885-016-2051-5},
  url = {https://doi.org/10.1186/s12885-016-2051-5}
}

RIS

TY  - JOUR
TI  - Correlation of KIT and PDGFRA mutational status with clinical benefit in patients with gastrointestinal stromal tumor treated with sunitinib in a worldwide treatment-use trial
AU  - Peter Reichardt
AU  - George D. Demetri
AU  - Hans Gelderblom
AU  - Piotr Rutkowski
AU  - Seock-Ah Im
AU  - Sudeep Gupta
AU  - Yoon-Koo Kang
AU  - Patrick Schöffski
AU  - Jochen Schuette
AU  - Denis Soulières
AU  - Jean-Yves Blay
AU  - David Goldstein
AU  - Kolette Fly
AU  - Xin Huang
AU  - Massimo Corsaro
AU  - Maria Jose Lechuga
AU  - Jean-Francois Martini
AU  - Michael C. Heinrich
PY  - 2016
JO  - BMC Cancer
DO  - 10.1186/s12885-016-2051-5
UR  - https://doi.org/10.1186/s12885-016-2051-5
ER  -

APA

Reichardt, P., Demetri, G. D., Gelderblom, H., Rutkowski, P., Im, S., Gupta, S., Kang, Y., Schöffski, P., Schuette, J., Soulières, D., Blay, J., Goldstein, D., Fly, K., Huang, X., Corsaro, M., Lechuga, M. J., Martini, J., & Heinrich, M. C. (2016). Correlation of KIT and PDGFRA mutational status with clinical benefit in patients with gastrointestinal stromal tumor treated with sunitinib in a worldwide treatment-use trial. BMC Cancer. https://doi.org/10.1186/s12885-016-2051-5

Source records

crossref · retrieved 2026-09-26T10:43:45.364Z